WI SB22 | 2019-2020 | Regular Session

Status

Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 7-4)
Status: Failed on April 1 2020 - 100% progression
Action: 2020-04-01 - Failed to pass pursuant to Senate Joint Resolution 1
Text: Latest bill text (Introduced) [PDF]

Summary

An Act to amend 100.30 (6) (title); and to create 100.30 (6) (a) 10. and 100.30 (6) (e) of the statutes; Relating to: regulating the sale of prescription drugs below cost. (FE)

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Regulating the sale of prescription drugs below cost. (FE)

Sponsors


History

DateChamberAction
2020-04-01SenateFailed to pass pursuant to Senate Joint Resolution 1
2019-03-19SenateSenator Kooyenga added as a coauthor
2019-02-15SenateFiscal estimate received
2019-02-08SenateRead first time and referred to Committee on Economic Development, Commerce and Trade
2019-02-08SenateIntroduced

Wisconsin State Sources


Bill Comments

feedback